Geranium Oil Protects Against Cefotaxime-Induced Liver and Kidney Damage in Rats
Author Information
Author(s): Azzam Shaimaa M., Elsanhory Heba M. A., Abd El-Slam Ahmed H., Diab Marwa S. M., Ibrahim Halima Mohamed, Yousef Abdalrahman Mohammed, Sabry Fatma Mahmoud, Khojah Ebtihal Y., Bokhari Somaiah A., Salem Gad Elsayed Mohamed, Zaghloul Marwa Saad
Primary Institution: Department of Biochemistry, Egyptian Drug Authority (EDA), Formerly National Organization for Drug Control and Research (NODCAR), Giza, Egypt
Hypothesis
The metabolism of cefotaxime, oxidative stress, and the overactivation of the MAPK and NF-κB signaling pathways are related to the liver damage caused by cefotaxime.
Conclusion
Geranium oil effectively mitigates the liver and kidney damage caused by cefotaxime in rats.
Supporting Evidence
- Geranium oil significantly reduced cefotaxime-induced damage, evidenced by lower serum levels of liver enzymes and renal markers.
- Histopathological analyses revealed significant protective effects in liver and renal tissues in rats treated with geranium oil.
- Geranium oil increased levels of protective tissue biomarkers such as NrF2, albumin, and catalase.
Takeaway
This study shows that geranium oil can help protect rats' livers and kidneys from damage caused by a common antibiotic called cefotaxime.
Methodology
Thirty male Wistar albino rats were divided into five groups and treated with different substances for 14 days, followed by biochemical and histopathological evaluations.
Potential Biases
Potential bias due to the lack of blinding in treatment allocation and outcome assessment.
Limitations
The study was conducted on a small sample size and only on male rats, which may limit the generalizability of the findings.
Participant Demographics
Male Wistar albino rats, aged 3–4 months and weighing between 170–200 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website